Abstract Details

Title Pregnancy Outcomes from the Teriflunomide Clinical Development Program: Retrospective Analysis of a Global Pharmacovigilance Database

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 190

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Olaf Stuve, MD, PhD, FAAN (UT Southwestern Medical Center)	Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Paul Matthews, MD (Imperial College, London)	No disclosure on file

��ɫ��